Determinants of Depressive Symptoms, Quality of Life, Subjective Health Status and Physical Limitation in Patients with Systemic Sclerosis
DOI:
https://doi.org/10.2340/actadv.v103.6502Keywords:
systemic sclerosis, quality of life, disability, depressive symptoms, epidemiologyAbstract
Systemic sclerosis is a progressive connective tissue disease for which there is limited knowledge about physical limitations, quality of life and depression. The aim of this study was to assess these parameters during the disease process of systemic sclerosis, in a cross- sectional study of 79 patients and a longitudinal study of 33 patients over 10 years. Medical data were collected by physicians’ questionnaires and sociodemographic data, pain, physical limitation, quality of life, subjective health status, risk of depressive symptoms by patients’ questionnaires. Data analysis was descriptive and exploratory. Cross-tabulations, χ2 test and Student’s t-test were used for calculations, Pearson’s correlation to measure dependencies, and logistic regression analyses for categorized parameters. The cross-sectional analysis of 79 patients with systemic sclerosis (81% female, mean ± standard deviation age 61.5 ± 12.6 years) demonstrated a higher rate of patients with risk of depressive symptoms (42.3%) higher physical limitations, lower quality of life, and subjective health status than reference values for the general German population. Moderate to strong correlations between disease-related physical limitation, quality of life, subjective health status, risk of depressive symptoms and pain were detected (correlation according to Pearson –0.459 to –0.638, p < 0.001). Longitudinal analysis revealed a significant increase in disease activity, pain, physical limitation and risk of depressive symptoms (p < 0.001) during the disease process. This study demonstrates that nearly half of patients with systemic sclerosis probably experience depressive symptoms. The rate of patients with risk of depressive symptoms, pain and physical limitations increased during the systemic sclerosis disease process. Health-related quality of life and state of health declined, indicating the need for better interdisciplinary care for patients with systemic sclerosis.
Downloads
References
Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, et al. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 2017; 31: 1401-1424.
https://doi.org/10.1111/jdv.14458 DOI: https://doi.org/10.1111/jdv.14458
Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008; 37: 223-235.
https://doi.org/10.1016/j.semarthrit.2007.05.003 DOI: https://doi.org/10.1016/j.semarthrit.2007.05.003
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
Masi AT. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
https://doi.org/10.1002/art.1780230510 DOI: https://doi.org/10.1002/art.1780230510
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013; 72: 1747-1755. DOI: https://doi.org/10.1136/annrheumdis-2013-eular.238
https://doi.org/10.1136/annrheumdis-2013-204424 DOI: https://doi.org/10.1136/annrheumdis-2013-204424
Mierau R, Moinzadeh P, Riemekasten G, Melchers I, Meurer M, Reichenberger F, et al. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther 2011; 13: R172.
https://doi.org/10.1186/ar3495 DOI: https://doi.org/10.1186/ar3495
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al.; EUSTAR Coauthors. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2017; 76: 1327-1339.
https://doi.org/10.1136/annrheumdis-2016-209909 DOI: https://doi.org/10.1136/annrheumdis-2016-209909
Bongi SM, Del Rosso A, Passalacqua M, Miccio S, Cerinic MM. Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase. Arthritis Care Res (Hoboken) 2011; 63: 1134-1141.
https://doi.org/10.1002/acr.20487 DOI: https://doi.org/10.1002/acr.20487
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, et al.; SENSCIS Trial investigators. nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 2019; 380: 2518-2528.
https://doi.org/10.1056/NEJMoa1903076 DOI: https://doi.org/10.1056/NEJMoa1903076
Smirani R, Truchetet ME, Poursac N, Naveau A, Schaeverbeke T, Devillard R. Impact of systemic sclerosis oral manifestations on patients' health-related quality of life: a systematic review. J Oral Pathol Med 2018; 4: 808-815.
https://doi.org/10.1111/jop.12739 DOI: https://doi.org/10.1111/jop.12739
Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 2005; 32: 51-57.
Stein J, Luppa M, Mahnke J, Weyerer S, Schomerus G, Riedel-Heller SG. Depressionsscreening am Telefon mittels der Allgemeinen Depressionsskala (ADS) [Screening for depression by telephone using the German version of the Center for Epidemiological Studies Depression Scale (CES-D)]. Psychiatr Prax 2014; 41: 135-141.
https://doi.org/10.1055/s-0033-1343176 DOI: https://doi.org/10.1055/s-0033-1343176
Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, Koarada S, et al. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 2003; 30: 1782-1787.
Kwakkenbos L, Arthurs E, van den Hoogen FH, Hudson M, van Lankveld WG, Baron M et al; Canadian Scleroderma Research Group. Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patients. PLoS One 2013; 8: e53923.
https://doi.org/10.1371/journal.pone.0053923
Nguyen C, Ranque B, Baubet T, Bérezné A, Mestre-Stanislas C, Rannou F, et al.; Groupe Français de Recherche sur la Sclérodermie. Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey. PLoS One 2014; 9: e90484.
https://doi.org/10.1371/journal.pone.0090484 DOI: https://doi.org/10.1371/journal.pone.0090484
March C, Huscher D, Preis E, Makowka A, Hoeppner J, Buttgereit F, et al. Prevalence, risk factors and assessment of depressive symptoms in patients with systemic sclerosis. Arch Rheumatol 2019; 34: 253-261.
https://doi.org/10.5606/ArchRheumatol.2019.7111 DOI: https://doi.org/10.5606/ArchRheumatol.2019.7111
Müller H, Rehberger P, Günther C, Schmitt J. Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma. Br J Dermatol 2012; 166: 343-353.
https://doi.org/10.1111/j.1365-2133.2011.10624.x DOI: https://doi.org/10.1111/j.1365-2133.2011.10624.x
Nikiphorou E, Radner H, Chatzidionysiou K, Desthieux C, Zabalan C, van Eijk-Hustings, et al. Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Res Ther 2016; 18: 251.
https://doi.org/10.1186/s13075-016-1151-6 DOI: https://doi.org/10.1186/s13075-016-1151-6
Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord 2017; 2: 11-18.
https://doi.org/10.5301/jsrd.5000231 DOI: https://doi.org/10.5301/jsrd.5000231
Langer HE. 2004. HAQ (Health Assessment Questionnaire) - rheuma-online. HAQ (Health Assessment Questionnaire) [accessed 2022 Dec 28]. Available from: https://www.rheuma-online.de/a-z/h/haq-health-assessment-questionnaire/
EuroQol Research Foundation. 2018. EQ-5D User Guides - EQ-5D. [accessed 2022 Dec 28]. Available from: https://euroqol.org/publications/user-guides/
Szende A, Janssen B, Cabases J, editors. Self-Reported population health: an international perspective based on EQ-5D. Dordrecht (NL): Springer; 2014. PMID: 29787044.
https://doi.org/10.1007/978-94-007-7596-1 DOI: https://doi.org/10.1007/978-94-007-7596-1
Thombs BD, Hudson M, Schieir O, Taillefer SS, Baron M; Canadian Scleroderma Research Group. Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. Arthritis Rheum 2008; 59: 438-443.
https://doi.org/10.1002/art.23329 DOI: https://doi.org/10.1002/art.23329
Kwakkenbos L, Arthurs E, van den Hoogen FH, Hudson M, van Lankveld WG, Baron M, van den Ende CH, Thombs BD; Canadian Scleroderma Research Group. Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patients. PLoS One 2013; 8: e53923.
https://doi.org/10.1371/journal.pone.0053923 DOI: https://doi.org/10.1371/journal.pone.0053923
Riediger M, Linden M, Wilms H-U. 1998. Die deutsche Version der CES-D als Instrument der gerontologischen Forschung. Zeitschrift für Klinische Psychologie, Psychiatrie und Psychotherapie, 46 (4): 344-364 [accessed 2022 Dec 28]. Available from: http://library.mpib-berlin.mpg.de/ft/mr/MR_Deutsche_1998.pdf.
Municipal Statistical Office Dresden. 2018. Municipal Citizens' Survey Dresden 2018 [accessed 2022 Dec 28]. Available from: https://www.dresden.de/media/pdf/onlineshop/statistikstelle/KBU_2018_Hauptaussagen.pdf.
Öffentlichkeitsarbeit, R. K. und. (o. J.). Rentner-Sozialberichterstattung-Sachsen.de. [accessed 2022 Oct 24]. Available from: https://www.sozialbericht.sachsen.de/rentner-4149.html.
Hapke U, Cohrdes C, Nübel J. Depressive symptoms in a European comparison - Results from the European Health Interview Survey (EHIS) 2. J Health Monit 2019; 4: 57-65.
Park EH, Strand V, Oh YJ, Song YW, Lee EB. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther 2019; 21: 61.
https://doi.org/10.1186/s13075-019-1842-x DOI: https://doi.org/10.1186/s13075-019-1842-x
Patel KR, Immaneni S, Singam V, Rastogi S, Silverberg JI. Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis. J Am Acad Dermatol 2019; 80: 402-410.
https://doi.org/10.1016/j.jaad.2018.08.063 DOI: https://doi.org/10.1016/j.jaad.2018.08.063
Richards HL, Fortune DG, Weidmann A, Sweeney SK, Griffiths CE. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol 2004; 151: 1227-1233.
https://doi.org/10.1111/j.1365-2133.2004.06221.x DOI: https://doi.org/10.1111/j.1365-2133.2004.06221.x
Tedeschini E, Pingani L, Simoni E, Ferrari D, Giubbarelli C, Giuggioli D, et al. Correlation of articular involvement, skin disfigurement and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample. Int J Rheum Dis 2014; 17: 186-194.
https://doi.org/10.1111/1756-185X.12100 DOI: https://doi.org/10.1111/1756-185X.12100
Mouthon L, Mestre-Stanislas C, Bérezné A, Rannou F, Guilpain P, Revel M, et al. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis 2010; 69: 214-217.
https://doi.org/10.1136/ard.2008.094193 DOI: https://doi.org/10.1136/ard.2008.094193
Evers C, Jordan S, Maurer B, Becker MO, Mihai C, Dobrota R, et al. Pain chronification and the important role of non-disease-specific symptoms in patients with systemic sclerosis. Arthritis Res Ther 2021; 23: 34.
https://doi.org/10.1186/s13075-021-02421-1 DOI: https://doi.org/10.1186/s13075-021-02421-1
Knafo R, Haythornthwaite JA, Heinberg L, Wigley FM, Thombs BD. The association of body image dissatisfaction and pain with reduced sexual function in women with systemic sclerosis. Rheumatology (Oxford) 2011; 50: 1125-1130.
https://doi.org/10.1093/rheumatology/keq443 DOI: https://doi.org/10.1093/rheumatology/keq443
Ostojic P, Jankovic K, Djurovic N, Stojic B, Knezevic-Apostolski S, Bartolovic D. Common causes of pain in systemic sclerosis: frequency, severity, and relationship to disease status, depression, and quality of life. Pain Manag Nurs 2019; 20: 331-336.
https://doi.org/10.1016/j.pmn.2019.02.006 DOI: https://doi.org/10.1016/j.pmn.2019.02.006
Racine M, Hudson M, Baron M, Nielson WR; Canadian Scleroderma Research Group. The impact of pain and itch on functioning and health-related quality of life in systemic sclerosis: an exploratory study. J Pain Symptom Manage 2016; 52: 43-53.
https://doi.org/10.1016/j.jpainsymman.2015.12.314 DOI: https://doi.org/10.1016/j.jpainsymman.2015.12.314
Sierakowska M, Doroszkiewicz H, Sierakowska J, Olesińska M, Grabowska-Jodkowska A, Brzosko M, et al. Factors associated with quality of life in systemic sclerosis: a cross-sectional study. Qual Life Res 2019; 28: 3347-3354.
https://doi.org/10.1007/s11136-019-02284-9 DOI: https://doi.org/10.1007/s11136-019-02284-9
van Leeuwen NM, Ciaffi J, Liem SIE, Huizinga TWJ, de Vries-Bouwstra JK. Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants. Rheumatology (Oxford) 2021; 60: 3646-3655.
https://doi.org/10.1093/rheumatology/keaa827 DOI: https://doi.org/10.1093/rheumatology/keaa827
Morrisroe K, Hudson M, Baron M, de Vries-Bouwstra J, Carreira PE, Wuttge DM, et al. International Systemic Sclerosis Inception Cohort (INSYNC) collaboration. Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort. Clin Exp Rheumatol 2018; 113: 53-60.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Stefanie Heyne, Eva Haufe, Stefan Beissert, Jochen Schmitt, Claudia Günther
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
